严格血压控制与APOL1基因型相关的死亡风险降低相关
该研究对非洲裔美国人肾脏病与高血压研究试验中682例已知APOL1基因型的慢性肾脏病黑人患者进行回顾性分析,比较严格与常规血压控制对死亡风险的影响。中位随访14.5年,APOL1高风险组中严格血压控制较常规血压控制死亡风险降低42%(HR 0.58,95%CI 0.35-0.97),低风险组无显著差异。
要点
- APOL1高风险基因型黑人CKD患者中,严格血压控制与死亡风险降低相关(HR 0.58)。
- APOL1低风险基因型者中,严格与常规血压控制的死亡风险无显著差异(HR 1.09)。
- APOL1基因型与血压控制策略间存在显著交互作用。
核心结论
- 在具有APOL1高风险基因型的黑人CKD患者中,严格血压控制与较低的死亡风险相关。
- 了解APOL1状态可能有助于选择黑人CKD患者的血压治疗目标。
研究设计与样本
- 对非洲裔美国人肾脏病与高血压研究试验的回顾性分析,该试验于1995年至2001年将黑人CKD患者随机分配至严格或常规血压控制。
- 纳入682例已知APOL1基因型的参与者,其中157例为高风险基因型,先前被分配至严格(平均动脉压[MAP]≤92 mm Hg)或常规血压控制(MAP 102-107 mm Hg)。
主要发现
- 中位随访14.5年期间,APOL1高风险与低风险基因型个体间的死亡风险无差异(未校正HR 1.00,95%CI 0.76-1.33)。
- 检测到APOL1风险组与血压控制策略间存在显著交互作用。
- APOL1高风险组中,严格较常规血压控制的死亡风险降低42%(HR 0.58,95%CI 0.35-0.97)。
- APOL1低风险组中,严格与常规血压控制的死亡风险无显著差异(HR 1.09,95%CI 0.84-1.43)。
临床怎么用
- 作者认为,了解APOL1状态可能有助于选择黑人CKD患者的血压治疗目标。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Although APOL1 high-risk genotype partially accounts for the increased susceptibility of blacks to chronic kidney disease (CKD), whether APOL1 associates differentially with mortality risk remains controversial. Here we evaluate the association between APOL1 genotype and risk of death and determine whether APOL1 status modifies the association between strict versus usual blood pressure control and mortality risk. We performed a retrospective analysis of the African American Study of Kidney Disease and Hypertension trial that randomized black participants with CKD to strict versus usual blood pressure control from 1995 to 2001. This included 682 participants with known APOL1 genotype (157 with high-risk genotype) previously assigned to either strict (mean arterial pressure [MAP] 92 mm Hg or less) versus usual blood pressure control (MAP 102-107 mm Hg) during the trial. During a median follow-up of 14.5 years, risk of death did not differ between individuals with high- versus low-risk APOL1 genotypes (unadjusted hazard ratio 1.00 [95% confidence interval 0.76-1.33]). However, a significant interaction was detected between the APOL1 risk group and blood pressure control strategy. In the APOL1 high-risk group, the risk of death was 42% lower comparing strict versus usual blood pressure control (0.58 [0.35-0.97]). In the APOL1 low-risk group, the risk of death comparing strict versus usual blood pressure control was not significantly different (1.09 [0.84-1.43]). Thus, strict blood pressure control during CKD associates with a lower risk of death in blacks with the high-risk CKD APOL1 genotype. Knowledge of APOL1 status could inform selection of blood pressure treatment targets in black CKD patients.
引用
- Ku E, Lipkowitz MS, Appel LJ, et al. Strict blood pressure control associates with decreased mortality risk by APOL1 genotype. Kidney Int. 2016. PMID: 27927600. doi:10.1016/j.kint.2016.09.033
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。